Intravenous Immunoglobulin for Treatment of Mild-To-Moderate Alzheimer's Disease: A Phase 2, Randomised, Double-Blind, Placebo-Controlled, Dose-Finding Trial

AuthID
P-00F-XQR
23
Author(s)
Dodel, R
·
Rominger, A
·
Bartenstein, P
·
Blennow, K
·
Forster, S
·
Winter, Y
·
Bach, JP
·
Popp, J
·
Alferink, J
·
[+3]·
Jacoby, M
·
Richter, R
·
Stevens, J
·
Melamed, I
·
Goldstein, J
·
Haag, S
·
Wietek, S
·
Farlow, M
·
Jessen, F
Document Type
Article
Year published
2013
Published
in The Lancet Neurology, ISSN: 1474-4422
Volume: 12, Issue: 3, Pages: 233-243
Indexing
Publication Identifiers
Pubmed: 23375965
Scopus: 2-s2.0-84876307732
Source Identifiers
ISSN: 1474-4422
Export Publication Metadata
Marked List
Citations
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.



CORE Conference
No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Name Order Name   Name Order Name   Name Order Name
1 Dodel, R;   2 Rominger, A;   3 Bartenstein, P;
4 Barkhof, F;   5 Blennow, K;   6 Forster, S;
7 Winter, Y;   8 Bach, JP;   9 Popp, J;
10 Alferink, J;   11 Wiltfang, J;   12 Buerger, K;
13 Otto, M;   14 Antuono, P;   15 Jacoby, M;
16 Richter, R;   17 Stevens, J;   18 Melamed, I;
19 Goldstein, J;   20 Haag, S;   21 Wietek, S;
22 Farlow, M;   23 Jessen, F;